# IBUPROFEN
> **ANDA220239** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2026-03-05
## Drug
- **FDA Application Number:** ANDA220239
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBUPROFEN
- **Generic name:** IBUPROFEN
- **Active ingredients:** IBUPROFEN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Ltd.
- **First approval:** 2026-03-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220239)
---
*AI Analytics · CC0 1.0*